Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Life Sciences Gains 6%; BSE HEALTHCARE Index Down 0.0%
Thu, 28 Nov 9:56

Suven Life Sciences Gains 6%; BSE HEALTHCARE Index Down 0.0%Image source: peterschreiber.media/www.istockphoto.com

Suven Life Sciences share price has zoomed 6% and is presently trading at Rs 126.0.

Meanwhile, the BSE HEALTHCARE index is at 42,990.8 .

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 1.9%) and CAPLIN POINT (up 1.4%).

AJANTA PHARMA (down 1.9%) and KIMS (down 1.9%) are among the top losers today.

Over the last one year, Suven Life Sciences has moved up from Rs 84.3 to Rs 126.0, registering a gain of Rs 41.8 (up 49.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 42,990.8, registering a gain of 45.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.8%), Glenmark Pharma (up 96.9%) and SUVEN PHARMACEUTICALS (up 94.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,248.8 .

The top gainers among the BSE Sensex today are MUNDRA PORT & SEZ (up 1.4%) and HDFC Bank (up 1.2%). The most traded stocks in the BSE Sensex are MUNDRA PORT & SEZ and Axis Bank.

In the meantime, NSE Nifty is at 24,296.5 (up 0.1%). Adani Enterprises and Shriram Transport are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 80,248.8, registering a gain of 14,074.6 points (up 21.3%).

Suven Life Sciences Financial Update...

Suven Life Sciences net profit fell 291.5% YoY to Rs -496 million for the quarter ended September 2024, compared to a loss of Rs 127 million a year ago. Net sales declined 15.9% to Rs 26 million during the period as against Rs 31 million in July-September 2023.

For the year ended March 2024, Suven Life Sciences reported 11.2% increase in net profit to Rs -1,051 million compared to net loss of Rs 1,183 million during FY23. Revenue of the company fell 13.6% to Rs 117 million during FY24.

The current Price to earnings ratio of Suven Life Sciences, based on rolling 12 month earnings, stands at -18.8.


Equitymaster requests your view! Post a comment on "Suven Life Sciences Gains 6%; BSE HEALTHCARE Index Down 0.0%". Click here!